These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17099918)

  • 1. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform.
    Bagalkot V; Farokhzad OC; Langer R; Jon S
    Angew Chem Int Ed Engl; 2006 Dec; 45(48):8149-52. PubMed ID: 17099918
    [No Abstract]   [Full Text] [Related]  

  • 2. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
    Bidwell GL; Fokt I; Priebe W; Raucher D
    Biochem Pharmacol; 2007 Mar; 73(5):620-31. PubMed ID: 17161827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates.
    Lee IH; An S; Yu MK; Kwon HK; Im SH; Jon S
    J Control Release; 2011 Nov; 155(3):435-41. PubMed ID: 21641946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and synthesis of androgen receptor-targeted nonsteroidal anti-androgen ligands for the tumor-specific delivery of a doxorubicin-formaldehyde conjugate.
    Cogan PS; Koch TH
    J Med Chem; 2003 Nov; 46(24):5258-70. PubMed ID: 14613328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polyvalent aptamer system for targeted drug delivery.
    Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
    Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cell targeting using multiple aptamers conjugated on nanorods.
    Huang YF; Chang HT; Tan W
    Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery.
    Niu W; Chen X; Tan W; Veige AS
    Angew Chem Int Ed Engl; 2016 Jul; 55(31):8889-93. PubMed ID: 27311814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible cell-specific drug delivery with aptamer-functionalized liposomes.
    Cao Z; Tong R; Mishra A; Xu W; Wong GC; Cheng J; Lu Y
    Angew Chem Int Ed Engl; 2009; 48(35):6494-8. PubMed ID: 19623590
    [No Abstract]   [Full Text] [Related]  

  • 14. Aptamer-based liposomes improve specific drug loading and release.
    Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
    J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer.
    Savla R; Taratula O; Garbuzenko O; Minko T
    J Control Release; 2011 Jul; 153(1):16-22. PubMed ID: 21342659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer.
    Bagalkot V; Zhang L; Levy-Nissenbaum E; Jon S; Kantoff PW; Langer R; Farokhzad OC
    Nano Lett; 2007 Oct; 7(10):3065-70. PubMed ID: 17854227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double targeting and aptamer-assisted controlled release delivery of epirubicin to cancer cells by aptamers-based dendrimer in vitro and in vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Lavaee P; Jalalian SH; Robati RY; Abnous K
    Eur J Pharm Biopharm; 2016 May; 102():152-8. PubMed ID: 26987703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin.
    Ren Y; Wong SM; Lim LY
    Bioconjug Chem; 2007; 18(3):836-43. PubMed ID: 17407258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates.
    Zhang L; Radovic-Moreno AF; Alexis F; Gu FX; Basto PA; Bagalkot V; Jon S; Langer RS; Farokhzad OC
    ChemMedChem; 2007 Sep; 2(9):1268-71. PubMed ID: 17600796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.